U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C7H9N3O4S
Molecular Weight 231.229
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METHANIAZIDE

SMILES

OS(=O)(=O)CNNC(=O)C1=CC=NC=C1

InChI

InChIKey=GQZQCROBCYNTMU-UHFFFAOYSA-N
InChI=1S/C7H9N3O4S/c11-7(6-1-3-8-4-2-6)10-9-5-15(12,13)14/h1-4,9H,5H2,(H,10,11)(H,12,13,14)

HIDE SMILES / InChI
Molecular Formula C7H9N3O4S
Molecular Weight 231.229
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Methaniazide (metaniazide) is the methanesulfonate derivative of isoniazid with antibacterial properties. It is used used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.

Approval Year

Unknown
149,124

Conditions

ConditionModalityTargetsHighest PhaseProduct
Pulmonary tuberculosis
17
 Primary
Preclinical
Unknown

PubMed

Patents

US2010184811
3
US2015309021
7
US9016221
15

Sample Use Guides

In Vivo Use Guide
600 mg/day
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
GN8S7ZES0F
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966